Large-scale testing (Phase 3)Study completedNCT02570126
What this trial is testing
A Safety and Immune Study of 2 Types of GlaxoSmithKline's Varicella Vaccines Given as a 2-doses Course to Healthy Children 12-23 Months of Age.
Who this might be right for
Chicken-pox Illness (Varicella Virus Disease)Chickenpox
GlaxoSmithKline 1,236